Active Ingredient(s): Nanoparticle Albumin-Bound Paclitaxel
FDA Approved: * January 7, 2005
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Abraxane Overview

Protein-bound paclitaxel, also known as nanoparticle albumin–bound paclitaxel or nab-paclitaxel, is an injectable formulation of paclitaxel used to treat breast cancer, lung cancer and pancreatic cancer, among others. Paclitaxel kills cancer cells by preventing the normal breakdown of microtubules during cell division.[1][2][3] In this formulation, paclitaxel is bonded to albumin as a delivery vehicle.[4] It is manufacture...

Read more Abraxane Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Protein-bound_paclitaxel

Recent Abraxane Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Nanoparticle Albumin-Bound Paclitaxel
  • For Suspension: 100mg/vial
  • Injection: 6mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Abraxane: (1 result)

Sorted by National Drug Code
  • 68817-134 Abraxane 100 mg/20ml Intravenous Injection, Powder, Lyophilized, for Suspension by Abraxis Bioscience, LLC

Other drugs which contain Nanoparticle Albumin-Bound Paclitaxel or a similar ingredient: (6 results)